January 6 Star Witness Cassidy Hutchinson Is in the DOJ's Crosshairs
No Way: Sheila Cherfilus-McCormick Who Resigned Before Getting Expelled Is Running for Re-...
They Can’t Even Flip Burgers
Breaking Up 'Big Medicine' Won't Fix What Washington Broke
Clarence Thomas and Our Founding Principles
Blue States Are Bleeding Population and Congressional Seats — The Fiscal Reckoning Is...
Questioning Vaccines Isn’t Fringe — Even Among Harris Voters
Federal Employees Play Childish Games With Presidential Orders to Protect Their Own Agenda...
The 10 Commandments Are a Threat to Marxism
Swiss Neutrality, Chinese Utility: A Foreign Policy Conundrum
How the SPLC Profited by Smearing Groups Like Mine
Democrats Created Today's Insurance Mess. Republicans Are Fixing It.
Nigerian-Led Fraud Ring Defrauded Victims of More Than $50 Million, Feds Say
Florida Security Consultant Allegedly Faked 18 Employees to Pocket $258K in Pandemic Relie...
Feds: Tacoma Grocer Pocketed $600K by Trading Food Benefits for Cash
Tipsheet

Facing Severe Shortage of Covid Treatments, NY Dept. of Health Makes Highly Controversial Eligibility Rule

Facing Severe Shortage of Covid Treatments, NY Dept. of Health Makes Highly Controversial Eligibility Rule
U.S. Navy photo by Mass Communication Specialist 2nd Class Erwin Jacob Miciano

New York’s Department of Health issued a memo this week to health care providers and facilities in the state warning that there is a severe shortage of Covid-19 treatments.

Advertisement

In order to be eligible to receive oral antivirals or monoclonal antibody treatment products, patients need to meet five conditions. The first four are not controversial—there are age and weight requirements, having a mild or moderate case of Covid-19, and able to begin treatment within five days of symptoms. The fifth criterion, however, is more controversial. In addition to meeting the other requirements, patients must also “have a medical condition or other factors that increase their risk for severe illness."

The memo goes on to state, “Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from Covid-19."

So while white patients can certainly get the treatment, they must have another condition that elevates their risk of severe illness. 

Advertisement

Related:

COVID-19 NEW YORK

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement